Granted Patent
B2
US 7,638,541 · App. 11/964,461 · Granted Dec 29, 2009
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
Assignee:
Metabolex Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Compounds, compositions, and methods relating to 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine or a pharmaceutically acceptable salt thereof are provided for the treatment of Type II diabetes and other diseases associated with poor glycemic control.
Claims (2)
1. A compound that is 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of claim 1 .
Assignments (4)
RELEASE OF SECURITY INTEREST
Recorded Aug 7, 2015
From: SILICON VALLEY BANK; OXFORD FINANCE LLC
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 036307/0406 →
SECURITY AGREEMENT
Recorded Nov 22, 2013
From: CYMABAY THERAPEUTICS, INC.
To: SILICON VALLEY BANK; OXFORD FINANCE LLC
Reel/Frame 031710/0508 →
CHANGE OF NAME
Recorded Nov 6, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031589/0193 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 20, 2009
From: CHEN, XIN; CHENG, PENG; CLEMENS, L. EDWARD; JOHNSON, JEFFREY D.; MA, JINGYUAN; MURPHY, ALISON; NASHASHIBI, IMAD; RABBAT, CHRISTOPER J.; SONG, JIANGAO; WILSON, MARIA E.; ZHU, YAN; ZHAO, ZUCHUN
To: METABOLEX INC.
Reel/Frame 022713/0940 →
Continuity (2)
Provisional Application
6087790300
· Dec 28, 2006